Moderna Quarterly Income Statements Chart
Quarterly
|
Annual
Moderna Quarterly Income Statements Table
Quarterly
|
Annual
| Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| revenue: | |||||||||||||||||||||||||||
| net product sales | 114,000,000 | 86,000,000 | 938,000,000 | 1,820,000,000 | 184,000,000 | 167,000,000 | 2,793,000,000 | 1,757,000,000 | 293,000,000 | 1,828,000,000 | 4,859,000,000 | 3,120,000,000 | 4,531,000,000 | 5,925,000,000 | 6,935,000,000 | 4,810,000,000 | 4,197,000,000 | 1,733,000,000 | |||||||||
| other revenue | 28,000,000 | 22,000,000 | 28,000,000 | 42,000,000 | 57,000,000 | 18,000,000 | 74,000,000 | 51,000,000 | 34,000,000 | ||||||||||||||||||
| total revenue | 142,000,000 | 108,000,000 | 966,000,000 | 1,862,000,000 | 241,000,000 | 167,000,000 | 2,811,000,000 | 1,831,000,000 | 344,000,000 | 1,862,000,000 | 5,084,000,000 | 3,364,000,000 | 4,749,000,000 | 6,066,000,000 | 7,211,000,000 | 4,969,000,000 | 4,354,000,000 | 1,937,000,000 | 570,745,000 | 157,910,000 | 66,351,000 | 8,389,000 | 14,055,000 | 17,046,000 | 13,083,000 | 16,025,000 | |
| yoy | -41.08% | -35.33% | -65.64% | 1.69% | -29.94% | -91.03% | -44.71% | -45.57% | -92.76% | -69.30% | -29.50% | -32.30% | 9.07% | 213.16% | 1163.44% | 3046.73% | 6462.07% | 22989.76% | 3960.80% | 826.38% | 407.15% | -47.65% | |||||
| qoq | 31.48% | -88.82% | -48.12% | 672.61% | 44.31% | -94.06% | 53.52% | 432.27% | -81.53% | -63.38% | 51.13% | -29.16% | -21.71% | -15.88% | 45.12% | 14.12% | 124.78% | 239.38% | 261.44% | 137.99% | 690.93% | -40.31% | -17.55% | 30.29% | -18.36% | ||
| operating expenses: | |||||||||||||||||||||||||||
| cost of sales | 119,000,000 | 90,000,000 | 739,000,000 | 514,000,000 | 115,000,000 | 96,000,000 | 929,000,000 | 2,241,000,000 | 731,000,000 | 792,000,000 | 1,918,000,000 | 1,100,000,000 | 1,381,000,000 | 1,017,000,000 | 952,000,000 | 722,000,000 | 750,000,000 | 193,000,000 | |||||||||
| gross profit | 23,000,000 | 18,000,000 | 227,000,000 | 1,348,000,000 | 126,000,000 | 71,000,000 | 1,882,000,000 | -410,000,000 | -387,000,000 | 1,070,000,000 | 3,166,000,000 | 2,264,000,000 | 3,368,000,000 | 5,049,000,000 | 6,259,000,000 | 4,247,000,000 | 3,604,000,000 | 1,744,000,000 | |||||||||
| yoy | -81.75% | -74.65% | -87.94% | -428.78% | -132.56% | -93.36% | -40.56% | -118.11% | -111.49% | -78.81% | -49.42% | -46.69% | -6.55% | 189.51% | |||||||||||||
| qoq | 27.78% | -92.07% | -83.16% | 969.84% | 77.46% | -96.23% | -559.02% | 5.94% | -136.17% | -66.20% | 39.84% | -32.78% | -33.29% | -19.33% | 47.37% | 17.84% | 106.65% | ||||||||||
| gross margin % | 16.20% | 16.67% | 23.50% | 72.40% | 52.28% | 42.51% | 66.95% | -22.39% | -112.50% | 57.47% | 62.27% | 67.30% | 70.92% | 83.23% | 86.80% | 85.47% | 82.77% | 90.04% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | |
| research and development | 700,000,000 | 856,000,000 | 1,122,000,000 | 1,137,000,000 | 1,221,000,000 | 1,063,000,000 | 1,406,000,000 | 1,160,000,000 | 1,148,000,000 | 1,131,000,000 | 1,211,000,000 | 820,000,000 | 710,000,000 | 554,000,000 | 648,000,000 | 521,000,000 | 421,000,000 | 401,000,000 | 758,860,000 | 344,486,000 | 151,856,000 | 115,137,000 | 117,523,000 | 119,715,000 | 128,496,000 | 130,575,000 | |
| selling, general and administrative | 230,000,000 | 212,000,000 | 351,000,000 | 281,000,000 | 268,000,000 | 274,000,000 | 470,000,000 | 442,000,000 | 332,000,000 | 305,000,000 | 375,000,000 | 278,000,000 | 211,000,000 | 268,000,000 | 201,000,000 | 168,000,000 | 121,000,000 | 77,000,000 | |||||||||
| total operating expenses | 1,049,000,000 | 1,158,000,000 | 2,212,000,000 | 1,932,000,000 | 1,604,000,000 | 1,433,000,000 | 2,805,000,000 | 3,843,000,000 | 2,211,000,000 | 2,228,000,000 | 3,504,000,000 | 2,198,000,000 | 2,302,000,000 | 1,839,000,000 | 1,801,000,000 | 1,411,000,000 | 1,292,000,000 | 671,000,000 | 845,783,000 | 393,027,000 | 188,478,000 | 139,251,000 | 143,149,000 | 147,903,000 | 157,019,000 | 157,858,000 | |
| income from operations | -907,000,000 | -1,050,000,000 | -1,246,000,000 | -70,000,000 | -1,363,000,000 | -1,266,000,000 | 6,000,000 | -2,012,000,000 | -1,867,000,000 | -366,000,000 | 1,580,000,000 | 1,166,000,000 | 2,447,000,000 | 4,227,000,000 | 5,410,000,000 | 3,558,000,000 | 3,062,000,000 | 1,266,000,000 | -275,038,000 | -235,117,000 | -122,127,000 | -130,862,000 | -129,094,000 | -130,857,000 | -143,936,000 | -141,833,000 | |
| yoy | -33.46% | -17.06% | -20866.67% | -96.52% | -27.00% | 245.90% | -99.62% | -272.56% | -176.30% | -108.66% | -70.79% | -67.23% | -20.08% | 233.89% | -2067.00% | -1613.29% | -2607.23% | -1067.43% | 113.05% | 79.67% | -15.15% | -7.74% | |||||
| qoq | -13.62% | -15.73% | 1680.00% | -94.86% | 7.66% | -21200.00% | -100.30% | 7.77% | 410.11% | -123.16% | 35.51% | -52.35% | -42.11% | -21.87% | 52.05% | 16.20% | 141.86% | -560.30% | 16.98% | 92.52% | -6.67% | 1.37% | -1.35% | -9.09% | 1.48% | ||
| operating margin % | -638.73% | -972.22% | -128.99% | -3.76% | -565.56% | -758.08% | 0.21% | -109.89% | -542.73% | -19.66% | 31.08% | 34.66% | 51.53% | 69.68% | 75.02% | 71.60% | 70.33% | 65.36% | -48.19% | -148.89% | -184.06% | -1559.92% | -918.49% | -767.67% | -1100.18% | -885.07% | |
| interest income | 81,000,000 | 90,000,000 | 91,000,000 | 103,000,000 | 111,000,000 | 120,000,000 | 103,000,000 | 105,000,000 | 104,000,000 | 109,000,000 | 87,000,000 | 58,000,000 | 40,000,000 | 15,000,000 | 7,000,000 | 4,000,000 | 3,000,000 | 4,000,000 | 4,200,000 | 5,571,000 | 7,092,000 | 7,852,000 | 7,984,000 | 9,252,000 | 10,322,000 | 10,972,000 | |
| other income | 8,000,000 | -4,000,000 | -29,000,000 | -12,000,000 | -27,000,000 | -19,000,000 | -39,000,000 | -51,000,000 | 14,000,000 | -48,000,000 | -12,000,000 | -7,000,000 | -13,000,000 | -13,000,000 | -7,000,000 | -10,000,000 | -2,000,000 | -10,000,000 | -174,000 | -3,226,000 | -1,530,000 | -1,154,000 | -2,175,000 | -1,767,000 | -1,764,000 | -1,820,000 | |
| income before income taxes | -818,000,000 | -964,000,000 | -1,184,000,000 | 21,000,000 | -1,279,000,000 | -1,165,000,000 | 70,000,000 | -1,958,000,000 | -1,749,000,000 | -305,000,000 | 1,655,000,000 | 1,217,000,000 | 2,474,000,000 | 4,229,000,000 | 5,410,000,000 | 3,552,000,000 | 3,063,000,000 | 1,260,000,000 | -118,375,250 | -232,772,000 | -116,565,000 | -124,164,000 | -97,857,750 | -123,372,000 | -135,378,000 | ||
| benefit from income taxes | 7,000,000 | 7,000,000 | 4,500,000 | 8,000,000 | 10,000,000 | -147,000,000 | 1,672,000,000 | 190,000,000 | 174,000,000 | 277,000,000 | 572,000,000 | 542,000,000 | 219,000,000 | 283,000,000 | 39,000,000 | 1,473,000 | 864,000 | 148,000 | 66,000 | -24,000 | |||||||
| net income | -825,000,000 | -971,000,000 | -1,120,000,000 | 13,000,000 | -1,279,000,000 | -1,175,000,000 | 217,000,000 | -3,630,000,000 | -1,380,000,000 | 79,000,000 | 1,465,000,000 | 1,043,000,000 | 2,197,000,000 | 3,657,000,000 | 4,868,000,000 | 3,333,000,000 | 2,780,000,000 | 1,221,000,000 | -272,485,000 | -233,636,000 | -116,713,000 | -124,230,000 | -123,116,000 | -123,194,000 | -135,054,000 | -132,657,000 | |
| yoy | -35.50% | -17.36% | -616.13% | -100.36% | -7.32% | -1587.34% | -85.19% | -448.03% | -162.81% | -97.84% | -69.91% | -68.71% | -20.97% | 199.51% | -1886.52% | -1526.58% | -2481.91% | -1082.85% | 121.32% | 89.65% | -13.58% | -6.35% | |||||
| qoq | -15.04% | -13.30% | -8715.38% | -101.02% | 8.85% | -641.47% | -105.98% | 163.04% | -1846.84% | -94.61% | 40.46% | -52.53% | -39.92% | -24.88% | 46.05% | 19.89% | 127.68% | -548.10% | 16.63% | 100.18% | -6.05% | 0.90% | -0.06% | -8.78% | 1.81% | ||
| net income margin % | -580.99% | -899.07% | -115.94% | 0.70% | -530.71% | -703.59% | 7.72% | -198.25% | -401.16% | 4.24% | 28.82% | 31.00% | 46.26% | 60.29% | 67.51% | 67.08% | 63.85% | 63.04% | -47.74% | -147.96% | -175.90% | -1480.87% | -875.96% | -722.72% | -1032.29% | -827.81% | |
| net income per share | -0.7 | -0.59 | -0.31 | -0.35 | -0.36 | -0.37 | -0.41 | -0.4 | |||||||||||||||||||
| basic and diluted | -2.13 | -2.52 | -3.33 | ||||||||||||||||||||||||
| weighted-average common shares used in calculation of net income per share | |||||||||||||||||||||||||||
| basic and diluted | 388 | 386 | 384 | ||||||||||||||||||||||||
| earnings per share: | |||||||||||||||||||||||||||
| basic | -2.91 | 0.03 | -3.07 | 0.56 | -9.53 | -3.62 | 0.2 | 3.85 | 2.67 | 5.55 | 9.09 | 12.06 | 8.27 | 6.93 | 3.05 | ||||||||||||
| diluted | -2.91 | 0.03 | -3.07 | 0.56 | -9.53 | -3.62 | 0.19 | 3.66 | 2.53 | 5.24 | 8.58 | 11.29 | 7.7 | 6.46 | 2.84 | ||||||||||||
| weighted-average common shares used in calculation of earnings per share: | |||||||||||||||||||||||||||
| basic | 384 | 385 | 382 | 382 | 381 | 381 | 386 | 394 | 390 | 396 | 402 | 403 | 404 | 402 | 400 | ||||||||||||
| diluted | 384 | 399 | 382 | 382 | 381 | 381 | 405 | 416 | 412 | 419 | 426 | 431 | 434 | 431 | 430 | ||||||||||||
| weighted-average common shares used in calculation of net income per share: | |||||||||||||||||||||||||||
| basic and diluted | 388 | 386 | 384 | ||||||||||||||||||||||||
| (benefit from) benefit from income taxes | -369,000,000 | -384,000,000 | -169,000 | -178,000 | -324,000 | ||||||||||||||||||||||
| grant revenue | -65,000,000 | 144,000,000 | 183,000,000 | 126,000,000 | 262,000,000 | 140,000,000 | 139,000,000 | 194,000,000 | 341,370,000 | 145,694,000 | 37,909,000 | 3,932,000 | 3,502,000 | 3,708,000 | 3,053,000 | 1,910,000 | |||||||||||
| collaboration revenue | 290,000,000 | 100,000,000 | 35,000,000 | 15,000,000 | 14,000,000 | 19,000,000 | 18,000,000 | 10,000,000 | 29,503,000 | 12,216,000 | 28,442,000 | 3,187,000 | 10,046,000 | 9,614,000 | 9,842,000 | 13,301,000 | |||||||||||
| weighted-average common shares used in calculation of earnings per share | |||||||||||||||||||||||||||
| basic | 384 | 385 | 382 | 382 | 381 | 381 | 386 | 394 | 390 | 396 | 402 | 403 | 404 | 402 | 400 | ||||||||||||
| diluted | 384 | 399 | 382 | 382 | 381 | 381 | 405 | 416 | 412 | 419 | 426 | 431 | 434 | 431 | 430 | ||||||||||||
| general and administrative | 27,319,250 | 48,541,000 | 36,622,000 | 24,114,000 | 25,626,000 | 28,188,000 | 28,523,000 | 27,283,000 | |||||||||||||||||||
| net income per share | -0.7 | -0.59 | -0.31 | -0.35 | -0.36 | -0.37 | -0.41 | -0.4 | |||||||||||||||||||
| weighted-average common shares used in net income per share, basic and diluted | 394,682,744 | 380,531,488 | 353,105,021 | ||||||||||||||||||||||||
| collaboration revenue from related party | 1,270,000 | 507,000 | 3,724,000 | 188,000 | 814,000 | ||||||||||||||||||||||
| net income attributable to common stockholders | -123,116,000 | -123,194,000 | -135,054,000 | -132,657,000 | |||||||||||||||||||||||
| weighted-average common shares used in net income per share attributable to common stockholders, basic and diluted | 381,333,059 | 330,802,136 | 330,769,341 | 329,176,107 | 328,809,986 | ||||||||||||||||||||||
| income before benefit from income taxes | -132,681,000 |
We provide you with 20 years income statements for Moderna stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Moderna stock. Explore the full financial landscape of Moderna stock with our expertly curated income statements.
The information provided in this report about Moderna stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.